Discovery of novel ULK1 inhibitors by virtual screening, synthesis, in vitro assay and molecular dynamics simulations
Bioorganic Chemistry · 2026
DOI: 10.1016/j.bioorg.2026.109628 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026. Verfasst von Yifan Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, PR China. Hauptthemen laut MEDLINE: Autophagy-Related Protein-1 Homolog, Protein Kinase Inhibitors, Molecular Dynamics Simulation, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
The serine/threonine kinase UNC-51-like autophagy-activating kinase 1 (ULK1) has emerged as a promising target for cancer treatment. This study utilized an integrative approach combining computational and experimental methods to discover novel ULK1 inhibitors. Through molecular fingerprint similarity and shape-based screenings of the ChEMBL database, along with fragment growth modifications of DCC-3116, three datasets comprising a total of 1.5 million compounds were generated. A multi-level molecular docking workflow shortlisted 1520 compounds, from which 9 promising candidates (SX1-SX3, D1-D5, and CL130) were identified based on their strong binding modes, favorable binding free energies, and desirable ADMET properties. These candidate compounds were synthesized and demonstrated nanomolar inhibitory activity in the ULK1 ADP-Glo kinase assay. Notably, D1-D3 exhibited significantly higher inhibitory potency compared to the reference SBI-0206965 (IC50 = 38.19 nM), with IC50 values of 14.91 nM, 0.74 nM, and 1.06 nM, respectively. The anti-proliferation assay of D1 was conducted on HeLa cells, yielding an IC50 value of 0.83 μM. Molecular dynamics simulations further confirmed the stability of these compounds within the ULK1 binding pocket, while principal component analysis and dynamic cross-correlation matrix analyses revealed distinct conformational and binding behaviors. Binding free energy calculations indicated that the interactions between the candidate compounds and ULK1 were either stronger or comparable to those of SBI-0206965. Overall, these results suggest that SX1-SX3, and D1-D5 were promising ULK1 inhibitors, providing a solid foundation for further development as potential anticancer drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Life Science, Beijing University of Technology, Beijing 100124, PR China.
- Department of Chemistry, Tsinghua University, Beijing 100084, PR China. Electronic address: zhangxkzqj@163.com.
- School of Pharmacy, North China University of Science and Technology, Tangshan 063210, PR China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Han, H., Li, J., Wei, C., Zhang, X., Zhong, Q., Yan, H., & Wang, J. (2026). Discovery of novel ULK1 inhibitors by virtual screening, synthesis, in vitro assay and molecular dynamics simulations. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2026.109628
Vancouver
Yang Y, Han H, Li J, Wei C, Zhang X, Zhong Q, et al. Discovery of novel ULK1 inhibitors by virtual screening, synthesis, in vitro assay and molecular dynamics simulations. Bioorganic Chemistry. 2026. doi:10.1016/j.bioorg.2026.109628
BibTeX
@article{Yang2026,
author = {Yang, Yifan and Han, Huijie and Li, Jingjing and Wei, Chaochun and Zhang, Xiaokun and Zhong, Qidi and Yan, Hong and Wang, Juan},
title = {Discovery of novel ULK1 inhibitors by virtual screening, synthesis, in vitro assay and molecular dynamics simulations},
journal = {Bioorganic Chemistry},
year = {2026},
doi = {10.1016/j.bioorg.2026.109628}
}
EUVIMED